A major breakthrough in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential malignant suppressor protein is frequently disabled in several forms of malignancies, causing https://leftbookmarks.com/story21997049/nanobodies-reactivate-p53-a-potential-hope-for-malignant-therapy